decisionhealth Newsletters, Part B News - 2005 Issue 5 (May)
Coverage and analysis chief urges focus on Medicare patients for studies
Subscribe or sign in to view the full article.
Article Overview
This article explains a CMS coverage official’s concerns about the types of evidence submitted in support of new coverage requests and why Medicare-focused study populations matter. It also summarizes the newly described Coverage with Evidence Decision process, including how CMS ties limited coverage to simultaneous data collection and the broader policy context around coding and pricing for newly covered items and services. The piece is relevant to people tracking Medicare coverage policy, CMS guidance, and the relationship between coverage decisions, coding, and pricing timelines.
Why This Topic Matters
Readers involved in Medicare coverage, reimbursement policy, and evidence development need to understand how CMS evaluates supporting data and what the Coverage with Evidence Decision framework may require. The article highlights policy timing and administrative considerations that can affect coverage implementation for drugs, devices, and services.
Article Sections
-
CMS evidence concerns for Medicare-focused studies
Discusses CMS concerns about the evidence used to support coverage requests and the importance of study populations relevant to Medicare beneficiaries.
-
Coverage with Evidence Decision process
Summarizes the CMS approach to limited coverage tied to data collection and the request for public input on the published guidance.
-
Coding and pricing under the Medicare Modernization Act
Covers the policy context around coding and pricing timelines for newly covered items or services and the related Medicare Modernization Act provision.
What You Will Learn
- Why CMS emphasizes evidence from Medicare-relevant populations
- What the Coverage with Evidence Decision framework is intended to address
- How coverage decisions intersect with coding and pricing timelines
- Which CMS contact and public-comment process is mentioned in the article
Who Should Read This
- Medicare compliance professionals
- Health policy analysts
- Coding and reimbursement staff
- Payers and provider administrators
- Medical device and pharmaceutical stakeholders
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com